Table 1.
Characteristic | Overall (N = 268) | Pathogen-Positive Episode (n = 151) | ||
---|---|---|---|---|
HIV+ | HIV− | |||
n = 100 | n = 51 | P Value | ||
Age, mean (standard deviation), y | 42.6 (13.5) | 43.7 (11.6) | 33.0 (12.9) | <.001 |
Race/ethnicity | .38 | |||
White non-Hispanic | 178 (66.4) | 70 (70.0) | 34 (66.7) | |
Black | 30 (11.2) | 11 (11.0) | 6 (11.8) | |
Hispanic | 34 (12.7) | 10 (10.0) | 5 (9.8) | |
Asian | 14 (5.2) | 3 (3.0) | 5 (9.8) | |
Other | 12 (4.5) | 6 (6.0) | 1 (2.0) | |
Location of testinga | .05 | |||
Inpatient | 39 (14.6) | 12 (12.0) | 3 (5.9) | |
Outpatient | 186 (69.4) | 63 (63.0) | 42 (82.4) | |
Emergency department | 40 (14.9) | 25 (25.0) | 6 (11.8) | |
Additional testing | ||||
White blood cell count | 149 (55.6) | 63 (63.0) | 26 (51.0) | .21 |
Stool ova and parasites exam | 97 (36.2) | 36 (36.0) | 18 (35.3) | .99 |
Cryptosporidium, Cyclospora, and Isospora (Cystoisospora) | 48 (17.9) | 22 (22.0) | 8 (15.7) | .35 |
Neisseria gonorrhoeae /Chlamydia | 59 (22.0) | 30 (30.0) | 14 (27.5) | .89 |
Syphilis | 54 (20.1) | 28 (28.0) | 13 (25.5) | .89 |
Preexposure prophylaxis | 36 (13.4) | NA | 31 (60.8) | … |
Antiretroviral medications | 139 (51.9) | 82 (82.0) | NA | … |
CD4, median (IQR) | 375 (187–648) | 444 (187–697.5) | NA | |
Viral load | ||||
Undetectable, n (%) | 112 (41.8) | 61 (61.0) | NA | … |
Detectable, median (IQR) | 50 220 (1262.5–209 350) | 32 865 (554.5–359 000) | NA | … |
Abbreviations: HIV, human immunodeficiency virus; IQR, interquartile range; NA, not applicable.
aThree observations missing location of testing.